NeoGenomics (NASDAQ:NEO) Trading Down 7.5%
Should You Buy or Sell NeoGenomics Stock? Get The Latest NEO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Stay updated with breaking news from Pharma Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell NeoGenomics Stock? Get The Latest NEO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
NAV increases by 0.4% in February ● Princess Private Equity Holding Limited's net asset value increased by 0.4% to EUR 14.79 per... | March 31, 2023
GUANGZHOU, China, March 28, 2023 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company...
StockNews.com lowered shares of NeoGenomics (NASDAQ:NEO – Get Rating) from a hold rating to a sell rating in a research note published on Friday. A number of other equities analysts have also issued reports on the stock. Cowen raised their target price on shares of NeoGenomics from $14.00 to $20.00 and gave the stock an […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating)’s stock price rose 5% during mid-day trading on Monday . The stock traded as high as $17.80 and last traded at $17.71. Approximately 212,500 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 1,069,359 shares. The stock had previously closed at $16.87. […]